Pharmacokinetic variables of medium molecular weight cross linked chitosan nanoparticles to enhance the bioavailability of 5-fluorouracil and reduce the acute oral toxicity
To prepare glutaraldehyde-based cross-linked medium molecular weight chitosan nanoparticles encapsulated with 5-Fluorouracil (5-FU), to overcome dosing frequency as well as reducing acute oral toxicity and poor bioavailability of the drug. Medium molecular weight chitosan nanoparticles (MMWCH-NPs) w...
Main Authors: | Aisha Sethi, Mahmood Ahmad, Tayyaba Huma, Waqas Ahmad |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2021.1944398 |
Similar Items
-
Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study of the sustained release in vitro and in vivo
by: Li Sun, et al.
Published: (2017-09-01) -
Synthesis and Characterization of 5-Fluorouracil-Loaded Glutaraldehyde Crosslinked Chitosan Hydrogels
by: Zehra ÖZBAŞ, et al.
Published: (2016-11-01) -
Study on fluorouracil–chitosan nanoparticle preparation and its antitumor effect
by: Gaimin Chen, et al.
Published: (2016-05-01) -
Thermosensitive hydrogel based on chitosan and its derivatives containing medicated nanoparticles for transcorneal administration of 5-fluorouracil
by: Fabiano A, et al.
Published: (2017-01-01) -
Investigating the Release of Methotrexate and 5-Fluorouracil Anticancer Drugs from Multi-Layered Nanofiber Structure of Polycaprolactone/Chitosan
by: N. Poursharifi, et al.
Published: (2020-01-01)